In June 2021, Interventional Systems received FDA 510(k) clearance for its Micromate robot for percutaneous procedures. “We’ve seen Pedro and Srdjan blossom into two of the most knowledgeable, devoted and kind leaders we know, so we are looking forward to what’s to come.” About Interventional Systems and its surgical robot platform “Pedro and Srdjan have had a very active participation in the design, development and commercialization of our company’s products, and those skills make them most suitable for the new phase the company is entering, one entailing broader business development and the diversification of the products’ applications,” the blog said. Thank you, Michael.”Ĭosta and Milosavljevic both have several years under their belts in leadership roles at Interventional Systems. “These principles are now a part of our ethos and, even if we know that Michael is still going to be collaborating closely with us, even if it is in stealth mode, we are all going to miss him dearly. “Michael set the tone for what would be the company’s key values: a restless love for all good ideas, an unrelenting willingness to try new things and the absolute certainty that if you want to be surrounded by the best, you must treat them like so,” the post reads. In a blog posted on the company’s website, Interventional Systems’ said Vogele’s mark goes beyond that of a founder and CEO. The two new appointments join co-founder and CFO, Thomas Pfeifer, and COO Patrick Lambardt, in the company’s C-suite. Milosavljevic led Interventional Systems’ R&D team previously. Additionally, the company named Srdjan Milosavljevic chief technology officer (CTO). The company tabbed former chief product officer Pedro Costa to succeed him.

Michael Vogele, who founded Interventional Systems, intends to step down as CEO. Miniature surgical robot developer Interventional Systems announced a number of executive changes including a switch in the corner office.ĭr. Michael Vogele (right) with the company’s Micromate robotic platform.

Staples micromate